More forecasts: Atlanta 30 day forecast
Abbott Snaps Up Exact Sciences in $21 Billion Cancer Play, Madison Keeps the Prize
Mar 23, 2026
Abbott has closed its roughly $21B purchase of Exact Sciences, paying $105 a share and folding Cologuard and other cancer‑testing assets into its diagnostics arm while keeping Exact’s Madison operations intact.












